Cholesterol is a structural architect, not just a metabolic byproduct
In short: While often framed solely as a cardiovascular risk factor, cholesterol is an indispensable building block of life. It maintains the integrity of your cell membranes, facilitates vital signaling pathways, and serves as the precursor for essential hormones like vitamin D.
Cholesterol's biological necessity stems from its role in maintaining cellular membrane integrity and facilitating developmental morphogen pathways. Beyond structure, it is a critical component in steroidogenesis—the process by which the body produces steroid hormones—and plays a significant role in Hedgehog signal transduction. It also contributes to lipid raft assembly, which helps organize specific proteins within cell membranes for efficient signaling. It is also a fundamental component of exosomic integrity. Furthermore, it serves as a primary building block for vitamin D production.
The body maintains cholesterol homeostasis through four interdependent metabolic modules: de novo biosynthesis (the Bloch/Kandutsch-Russell pathways), intestinal absorption mediated by NPC1L1, enzymatic conversion into bile acids via the CYP7A1 enzyme, and systemic clearance. Severe conditions such as oncogenesis, neurodegenerative disorders, metabolic dysfunction-associated fatty liver disease (MAFLD), and atherosclerosis may arise if cholesterol flux pathways are hindered by faulty esterification cascades, efflux, or synthesis. The intestinal uptake process specifically relies on the niemann-pick C1-like 1 protein. These metabolic modules must work in precise coordination to ensure balance.
Modern medicine is shifting from broad-spectrum treatments like conventional statins toward precision cardiometabolic medicine. This includes innovative modalities such as CRISPR-based in vivo gene editing (specifically targeting PCSK9 via VERVE-101), siRNA therapeutics like inclisiran, and microbiota-directed interventions. These advancements aim to address residual cardiovascular risks by targeting specific proteins like ANGPTL3 and lipoprotein(a) [Lp(a)], moving toward personalized, multi-target regimens. Researchers are also exploring repurposed natural agents like berberine and probiotics as potential treatments. These therapies aim to mitigate risks that remain even after standard drug use.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Physiology of Lipoproteins Cholesterol
- Also: Cholesterol metabolism: molecular mechanisms, biological functions, diseases, and therapeutic targets
To cite this card, link to https://intellectplus.co.uk/app/science-physiology-of-lipoproteins-cholesterol.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Biochemistry · More in Science · Latest · A–Z · All topics